ACQUISITION–RELATED CHARGES (GAINS) AND OTHER - Narrative (Details) - USD ($) $ in Thousands |
1 Months Ended | 3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|---|
Nov. 19, 2021 |
Dec. 31, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Business Acquisition [Line Items] | ||||||
Changes in contingent consideration | $ (23,394) | $ (2,147) | ||||
Nuance Biotech Co. Ltd. | ||||||
Business Acquisition [Line Items] | ||||||
Estimated settlement fees | 3,000 | |||||
Flexion Acquisition | ||||||
Business Acquisition [Line Items] | ||||||
Changes in contingent consideration | $ 45,200 | $ 1,200 | $ 500 | 13,800 | ||
Flexion Acquisition | Legal Fees | ||||||
Business Acquisition [Line Items] | ||||||
Acquisition-related costs | 1,500 | $ 1,000 | 10,200 | 1,000 | ||
Myoscience Acquisition | ||||||
Business Acquisition [Line Items] | ||||||
Acquisition-related costs | 400 | 400 | ||||
Changes in contingent consideration | $ 523 | $ 1,159 | $ 9,557 | $ 2,147 |